Mediators of the innate immune response Flashcards

1
Q

Purpose of inflammation

A

Body attempting to dilute, destroy or isolate a noxious agent and repair damage. The most potent immune defence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cause of inflammation

A

Agents can be physical, chemical or biological.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Process of inflammation

A
Characterized by generation of inflammatory mediators and accumulation of fluid and leukocytes from blood into extracellular tissues
Can be resolved into 3 distinct phases -
1. Initiation
2. Amplification
3. Termination/ resolution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Initiation of inflammation

A

Structural changes leading to increased blood flow and extravasation of fluid.
Emigration of cells of the innate immune system to the site of injury via chemotaxis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Amplification of inflammation

A

Elevated cellular metabolism and releaee of inflammatory mediators which promote both local and systemic responses.
Chemotactic factors attract immune cells that invade surrounding tissues to fight infection (causes collateral damage).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Termination/resolution of inflammation

A

Accomplished by specific inhibition or dissipation of mediators.
Growth factor then promotes cell proliferation or repair in injured area.
Injured area may return to normal following repair or may proceed and form abscesses/ enter chronic phase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hallmark signs of inflammation

A

Injury, rubor, calor, tumor, dolor, loss of function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Vascular response to inflammation

A

Vasodilation
Capillary permeability/oedema
Pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cellular response to inflammation

A
Migration and pavementing of WBCs
Emigration
Chemotaxis
Phagocytosis
Controlled by soluble chemical messengers (chemokines and cytokines) released from activated leukocytes and vascular endothelial cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Coagulations role in immune response

A

Acts at the site of lesions to trap exudate, microorganisms and foreign bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Kinin pathway

A

Acts to increase vasodilation and eicosanoid synthesis

Activates B1 and B2 GPCRs, B1 is inducable by inflammatory stimuli.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Complement

A

Comrpises of >30 plasma and cell surface proteins
C1 - C9 are serum components
Engaged hy the innate immune system, and one of the main effectors of the adaptive immune response.
Mostly made in the liver and exists as inactive proenzymes that are then cleaved to generate the active enzyme components.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Functions of complement

A

Formation of MAC (membrane attack complex) that lyses gram-negative bacteria, viruses and cells.
Potentiates inflammation by binding to the receptors on mast cells causing the release of histamine (C3a, C4a, and C5a are anaphylatoxins)
Chemoattractant (C5a) increases the recruitment of inflammatory cells.
C3b, C4b and C5b enhance opsonisation by phagocytic cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MB-Lectin pathway

A

Homologous to the classical pathway
MBL forms complex with MASPs that structurally resemble C1 complex
Active MBL-bound MASP complex activates C4 and C2 zymogens which go on to activate C3 convertase
C3 convertase leads to formation of terminal complement proteins and therefore opsonisation and cell lysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Defective regulation of complement and disease

A

Complement is the key link between innate and adaptive imune responses via effects on multiple cell types.
Erroneous activation of insufficient regulation lead to disease.
C5a has a mojor role in psoriasis and asthma.
Deposition of immune complexes activates C1q in systematic lupus and RA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Is the complement pathway druggable?

A

Ser proteases and anaphlatoxin receptors and druggable targets.
Difficult to generate good drugs against as complement has a complex regulation which is not fully understood and finding the balance between supressing enhanced activation without compromising defensive function is difficult.
An example of a drug is compstatin, this is a C3 inhibitor that is in phase 2 triaks for treatment of age related macular degeneration.

17
Q

Histamine

A

Complexes with macroheparin and an acidic protein in intracellular granules of mast cells and basohpils.
Released by exocytosis following inflammatory/allergic reaction.
Stimulated by binding of C5a and C3a to complement receptors.
Binding of antigen and cross-linking of IgE receptors increases intracellular calcium concentration, therefore increasing exocytosis.
The H4 receptor on basoohils,eosinophils,mast cells and dendritic cells helps regulate histamine release. When coupled with Gi and PLCb histamine release increases.
H4 antagonists now being developed as future treatment for asthma.

18
Q

Nitric oxide

A

iNOS is involved in inflammation
All inflammatory cells increase iNOS synthesis following cytokine exposure.
NO binds and activates soluble guanylate cyclase, increasing cGMP.
iNOS-derived NO has mainly pro-inflammatory actions (increases vasodilation, vascular permeability and pro-inflammatory PG production.)
NO and its derivatives are cytotoxic to microbes (and host if NO is excessive)

19
Q

Eicosanoids

A

Derived from arachidonic acid
Fate controlled by the COX pathway
PG12, PGE2, PGD2 - vasodilate, increase bloocflow to inflamed areas.
PG12, PGD2 - Decrease platelet aggregation
PG12, PGE2 - Hyperanalgesia
PG12 - mostly from endothelium
PGE2 - produced in inflammatory conditions, pyrogen (increases COX-2 and PGE2 in hypothalamus)
PGD2 - mostly from mast cells, activated by allergen.
TXA2 - Antagonises PG effects, mostly from platelets, decreases vasodilation and increases platelet aggregation.

20
Q

Non-steroidal anti-inflammatory drugs (NSAIDs)

A

Example -
Non selective - aspirin, ibuprofen, paracetamol
COX-2 Selective - rofecoxib, celecoxib.

Analgesic (CNS and peripheral effects)
Antipyretic (CNS effects)
Anti-inflammatory (inhibits PGs)
NSAIDs block cyclooxygenase reaction.

21
Q

COX-1

A

Constituitively expressed
Roles in -
Inhibition of acid secretion/ maintenance of mucosa to protect stomach lining.
Platelet function

Side effects of NSAIDs due to COX-1 inhibition.
COX-2 selective inhibition would therefore be better. Selective NSAIDs could bind to the selective sidepocket that only COX-2 has and only inhibit COX-2

22
Q

Lipoxygenase pathway

A

CysLTs are vasodilators (except in the heart and lungs), potent bronchoconstrictors, important in airway inflammation.
LTB4 - increase PMN adherence, chemotaxis, lymphocyte and macropage function. Is mostly from neutrophils, important in akk types of inflammatory response.
12-HETE - increases PMN and macrophage chemotaxis.
Lipoxygenases - cytosolic enzymes found in lung platelets, mast cells and white blood cells.

23
Q

Drugs targetting LT pathways

A

Zileuton/ziflo -
A potent 5-Lipoxygenase inhibitor
Orally administered
Aporoved for prevention and treatment of chronic asthma.
Contraindications in patients with impaired liver function.

Zafirlukast/accolate -
LTD4 and LTE4 receptor-Selective peptidergic competitive antagonist.
Orally administered
Approved for prevention and treatment of asthma
Cannot be used in acute asthma attack
Contraindications in patients with impaired liver function.